and likely active site, revealing that despite no discernible sequence similarity TAATs are a structurally and functionally distinct group of the GNAT superfamily of modifying enzymes. Our findings open the way to further understanding of the unique toxin activation, and the possibility of inhibiting toxin action.
INTRODUCTION
Pathogenic bacteria secrete pore-forming protein toxins (PFTs) that target tissue and immune cell membranes to aid colonization and survival during infections, subvert cell signaling, induce apoptosis and promote cell lysis (1) (2) (3) (4) (5) (6) (7) (8) . Among Gram negative bacteria, large PFTs are secreted by pathogenic species of Pasteurella, Actinobacillus, Proteus, Morganella, Moraxella and Bordetella, exemplified by the 110kDa hemolysin (HlyA) of uropathogenic and enterohemorrhagic E.coli.
These toxins play important roles in cystitis and pyelonephritis, hemorrhagic intestinal disease, periodontitis, pneumonia, septicemia, whooping cough and wound infections (4) , and unusually they are made as an inactive protoxin, requiring post-translational activation before export (9-12).
Reconstituting the toxin activation reaction in vitro some time ago demonstrated that the essential modification is a novel fatty acid acylation, effected by a specialised coexpressed toxinactivating acyltransferase, in E.coli HlyC, that uses acyl-acyl carrier protein (acyl-ACP) as the fatty acid donor (4, 13, 14) . The acyltransferase does not share significant sequence identity with other bacterial and eukaryotic enzymes and cellular acyltransferases from either the host or pathogen cannot substitute for HlyC in toxin activation. HlyC independently binds two separate 50-80 amino acid transferase recognition domains (15) each encompassing one of the internal target lysines K564 and K690 of E.coli protoxin HlyA, which are acylated by amide linkage, heterogeneously with fatty acids containing 14, 15 and 17 carbon chains (16, 17) . Loss of the HlyC binding domain or substitution of protoxin K564 and K690, prevents fatty acyl modification and abrogates all toxin activity (14) as does loss of the transferase (18) .
Acylation is essential to the entire family of pore-forming toxins, B.pertussis proCyaA lysine acylation has also been demonstrated (19) , and the toxin-activating acyltransferases (which we now call TAATs) have high sequence similarity and cross-activate other protoxins (4, (20) (21) (22) . The TAAT activation mechanism is seemingly unique, and extensive site-directed mutagenesis has so far only identified a single potentially catalytic residue, His23 of HlyC (23-25). Structural information is essential to understand the toxin activation mechanism, and assess TAATs as a potential target for developing anti-virulence compounds that do not affect the host commensal flora. Here we determine the TAAT crystal structure, solution state, and likely active site.
RESULTS
The ApxC structure reveals TAATs as a distinct, closely conserved branch of the GNAT superfamily.
Multiple TAAT genes were cloned and expressed in E.coli and where possible TAAT proteins were purified and screened for their amenability to crystallisation. This yielded the crystal structure of the 172 amino acid Actinobacillus pleuropneumoniae ApxIC (hereafter ApxC) at 2.15Å resolution using the selenomethionine SAD method of phase determination. Crystallographic data and refinement statistics are given in Table S1 and the structure is shown in Figure 1 . Crystals belong to space group P2 1 2 1 2 1 with 4 molecules per asymmetric unit (Fig. 1a) . The four monomers are very similar and can be superposed pairwise with a mean rmsd of 1.7Å (Cα positions, residues 4-170).
Structural diversity is largely limited to the last 7 residues of the C-terminus (mean rmsd for residues 5-165 is 0.84Å), and is not expected to be of physiological relevance as this region is not well-conserved among TAATs. Each ApxC monomer is composed of a central five-membered β-sheet that is decorated by six α-helices (Fig. 1b) . A distinctive split in the sheet is located between strands β3 and β4 which are the only strands that run parallel with one another. This split β-sheet is a key feature of the underlying fold, establishing a deep groove in the enzyme surface.
The overall fold of ApxC is clearly related to the Gcn5-like N-Acetyl Transferase (GNAT) superfamily, confirmed using structural-similarity searches with Dali (26). GNAT superfamily members mediate a diverse range of prokaryotic and eukaryotic processes ranging over antibiotic detoxification, circadian rhythm regulation and polyketide biosynthesis (27, 28). The closest structural match is the GNAT-like domain of CurA (rmsd 2.8Å, Dali Z score=8.6) (29), but robust structural similarity is also evident with other GNATs including the histone acetyl transferases (HATs), Gcn5 (rmsd 3.2Å, Z=7.8) (35), p300/CBP (rmsd 3.1Å, Z=7.9) (30), Myst (rmsd 4.0Å, Z=3.1) (31), and acyl-amino acid synthase FeeM (rmsd 3.6Å, Z=6.6) (32). The ApxC structure is nonetheless distinguished from all other GNATs by the absence of a helical element that typically interacts with the planar nucleotide portion of CoA -this would be located between ApxC residues 122 and 129 (Fig. 1b, teal) , and the CoA diphosphate binding motif ("motif A" in GNATs (27)), that would otherwise be located between strand β3 and helix α3 (residues 97-99, Fig. 1b, orange) .
ApxC appears to be the only GNAT that lacks both of these two features, indeed the helix that is missing in ApxC is so uniformly conserved among GNATs that, alongside the split β-sheet, it is considered a defining feature of the GNAT fold (27, 28). In addition to the absence of CoAinteracting elements, the long (25 residue) α-helix at the extreme C-terminus of ApxC (Fig. 1b, violet) is absent from all known GNAT structures, and a short helix and loop (residues 74 -86, Fig. 1b, green) is present only in CurA (29). The close structural relationship between ApxC and members of the GNAT superfamily is remarkable given that there is no primary sequence similarity between these proteins. Even structure-driven sequence alignments produced with Dali reveal just 6.4% sequence identity between ApxC and its closest structural match, the CurA GNAT domain, barely above that expected by chance (5%).
In contrast to the low sequence identity between TAATs and other GNATs, the TAAT family itself is well conserved, illustrated by the multiple sequence alignment in Figure 2 . ApxC shares 70% primary sequence identity with the best studied TAAT, E.coli HlyC, and can directly substitute for HlyC in activation of the E.coli hemolysin toxin in vivo (Figure S1 ), suggesting the ApxC structure is representative of the TAAT family and allowing us to construct high confidence homology models of homologues E.coli HlyC and Bordetella pertussis CyaC (coordinates available in SI).
TAATs adopt a dimeric arrangement in solution, mediated by an N-terminal helical interface.
Gel filtration experiments using recombinant ApxC indicate an apparent molecular weight (42kDa) that is twice that expected for the monomer (21kDa) (Figure S2) . Examination of the crystal packing in the ApxC structure shows four arrangements that could conceivably represent this dimer (Dimers I to IV in Figure 3a) . Dimer I, underpinned by the unique C-terminal helix and Dimer III which appears twice in the asymmetric unit ( Figure S3 ) were attractive possibilities but it was not obvious by inspection which interface reflects the physiological dimer and which are crystal contacts.
We assessed the extent and quality of each of the four dimer interfaces by measuring the buried surface area and calculating the predicted stability using PISA (33) (Fig. 3a) . Dimer IV had the lowest buried surface area and was predicted to be unstable but Dimers I, III and IV had substantial buried surface area and were all predicted to be stable. Analysis of scattering data from small angle X-ray scattering (SAXS) (Fig. 3b) indicated that the particle has an estimated molecular weight of ~38.8kDa, a 28Å radius of gyration and a probable maximum dimension of ~77Å. Ab initio shape reconstructions of the solution particle were consistent with a 2-fold symmetric bilobal globular dimer (Fig. 3b) . Comparison of the scattering data with theoretical profiles predicted for each dimer was used to assess which arrangement most closely resembles the solution particle (Fig. 3c) . Both Dimer I and Dimer III have low χ 2 values indicating a good fit between prediction and experiment while Dimers II and IV do not. Inspection of the predicted P(r) profiles (Fig. 3c , black lines) shows that both Dimers I and III are close to the experimentallyderived profile (blue lines) consistent with bilobal structures with a maximum dimension of ~80 Å, while Dimers II and especially IV deviate significantly suggesting that the maximum dimensions of these dimers are respectively 10Å and 15Å too short to be consistent with the data. Taken together, the surface areas, predicted stabilities and SAXS data excluded Dimers II and IV but did not satisfactorily discern between Dimers I and III.
We therefore applied two further molecular genetic experimental approaches. Firstly, we conducted in vitro cross-linking experiments with the aim of covalently trapping the physiological dimer using experimentally-engineered cysteine residues placed independently at each potential dimerization interface. Secondly, we used a bacterial 2-hybrid system (34) to monitor the inter-monomer interaction in vivo after introducing disruptive mutations to each putative interface.
The interface structures, genetic interventions and results are presented in Figure 4 . Both Dimers I and III are 2-fold rotationally symmetric, so it was possible to introduce single cysteines close to the relevant rotation axis to generate potential cross-link sites, namely Gly12Cys within the Nterminal helix to specifically trap Dimer III, and Lys160Cys within the C-terminal helix to trap Dimer I (Fig. 4a) . Cross-linking of the dimer was successful with Gly12Cys, but not Lys160Cys, and no cross-linked dimer was generated by the wild type protein, nor when solvent accessible cysteines were pre-blocked with NEM (Fig. 4b) . In parallel, we used a bacterial 2-hybrid assay (34) in which wildtype ApxC dimerization results in reporter activity (β-galactosidase activity, blue spot, top box Fig. 4d ). Mutations were engineered to disrupt either the N-terminal helix within the Dimer III interface (Gly12Ala, Gly12Glu, Ala15Glu, and Ala19Glu substitutions, Fig. 4c ) or the intertwined C-termini of Dimer I by a 10 amino acid deletion (Fig. 4e) , all variant fusion proteins expressed comparably ( Figure S4) . The Gly12Glu and Ala15Glu mutation disrupted the dimer (white spots, Fig. 4d ), while deletion of the C-terminus had no effect (Fig. 4f) . Taken together these experiments unambiguously define Dimer III as the state of the enzyme in solution.
Identification of the TAAT active site within a deep surface groove.
The structural similarity between TAATs and the GNATs provoked a search for shared catalytic residues in structural superimpositions of ApxC with key members of the Gcn5 (35), Hat1 (30), Myst (36), p300/CBP (30), FeeM(32) and CurA (29) GNAT subfamilies. Statistics for the structural superpositions are given in Table S2 alongside summaries of the expected active site residues and the ApxC residues to which they most closely align. Our search confirmed that TAATs do not contain catalytic residues established for other GNATs including the buried glutamates found in the To confirm the location of the active site and to identify key residues, we generated alanine mutants of residues lining the groove, in particular targeting polar residues conserved in the TAAT family ( Fig. 2) . These included His24 for which the equivalent residue in E.coli TAAT HlyC has been shown to be important (24), Ser21 and Asp93 which together with His24 have a three dimensional arrangement reminiscent of catalytic triads found in non-GNAT acyltransferases and proteases). The structural context of these targeted residues is shown in Fig. 6a , and relative TAAT activities of ApxC alanine-variants assessed by erythrocyte lysis of variant-activated toxin are indicated in Fig. 6b . The Ser21Ala substitution caused only a marginal (21%) reduction in TAAT activity, inconsistent with a role as a nucleophile within a catalytic triad. A role for the TAAT family conserved cysteine residue can similarly be excluded as the ApxC structure reveals Cys58 is completely buried within the core of the protein where it is inaccessible to substrates (Fig S5a,   b ). In agreement with this, the Cys58Ala variant has wild type levels of activity (Fig. S5c) . In contrast, both Asp93 and Arg121 alanine variants were profoundly affected by mutation with TAAT activities less than 1% of the wild type. The His24 and Asn35 variants were also significantly impaired, although not to the same degree, with measurable activities of c.5% of wild type.
To probe the roles of these four important residues, we performed bacterial 2-hybrid experiments to assess their ability to engage with TAAT substrates (i.e. the protoxin and ACP). All four alanine-substituted variants were able to dimerise efficiently indicating that each is properly folded (Fig. 6c, left) , and all engaged with a 58 amino acid peptide (residues 679-736 of the protoxin) known to be the recognition sequence for TAAT spanning K690 (15) (Fig. 6c , centre).
Asn35, Asp93 and His24 alanine variants were also able to bind ACP, but the Arg121Ala mutant was not (Fig. 6c , right) despite being expressed at comparable level to the wild type ( Fig. 6b) . We therefore anticipate Arg121 mediates interaction with ACP while the remaining essential residues, His24, Asn35, and Asp93, are likely to have roles in catalysis. The putative active sites encompassing these residues in the surface groove are on opposing faces within the dimer, not in close juxtaposition (Fig. 6d ).
DISCUSSION
We have described the high resolution crystal structure ( Fig. 1) , solution structure ( loop-helix feature further distinguish TAATs from other GNATs (Fig. 1) .
In vitro SAXS (Fig. 3) and in vivo two-hybrid analyses (Fig. 4) confirmed indications from gel filtration (previously with HlyC (18) and here with ApxC) that TAATs are dimers in solution.
Analysis of biophysically tenable dimers abstracted from the crystal structure using a combination of experimental solution scattering data, targeted mutagenic disruption and cross-link locking of potential inter-monomer contacts, firmly established the dimer topology (Fig. 3a , Dimer III). The dimer interface is largely hydrophobic, with the close approach of the N-terminal helices facilitated by the small side chains of Gly12 and Ala15. Consequently, the proposed active sites of the monomers, each located within a surface groove, are topologically distinct within the context of the dimer and unlikely to act in concert (Fig. 6d) . Structure-led mutagenesis of the TAAT surface groove, the putative active site, revealed two residues, Asp93 and Arg121, as essential to function and Asn35 and His24 as important.
Mutation to alanine did not impair dimerisation, and while all four alanine variants still interacted with the target protoxin, mutation of Arg121 uniquely abrogated binding of ACP. In other unrelated ACP-binding enzymes positively charged residues mediate direct interactions with phosphates of the ACP phosphopantetheine group (37) or the negatively charged residues of ACP (38), and so it seems likely that Arg121 plays a similar role in the TAAT:ACP interaction. For Asn35, the chemistry of the asparagine side chain precludes a role in acid-base catalysis and amide group is unlikely to be a nucleophilic, but it may have a role in orientating substrates or other essential residues e.g. Asp93 to which it is hydrogen bonded.
His24 and Asp93 are both candidates to be true catalytic residues and plausible roles within the context of the two most likely acyl transfer schemes are outlined in Figure S6 . In the first scheme, a ternary complex is formed between the enzyme and both substrates facilitating direct nucleophilic attack of the protoxin target lysine on the acyl-ACP thioester with subsequent expulsion of ACP (a "direct attack" mechanism, In support of ternary complex formation, the TAAT surface groove is of comparable size to that of Gcn5 and so probably big enough to accommodate both the acylated phosphopantetheine arm of acyl-ACP and the protoxin lysine, if not also a substantial part of unfolded protoxin. Based on the superposition of TAATs with other GNATs (Fig. 5 ) and our identification of the TAAT catalytic residues (Fig. 6) we illustrate how TAATs could bring together the acyl-ACP and toxin substrates to effect toxin activation in Fig. 7 . The central location of the active site residues within the groove (yellow, Fig. 7b ) hints that each substrate could be bound on opposing faces of the enzyme with acyl transfer chemistry occurring at the crux of the split β-sheet. In support of this, the ACP-interacting arginine (Arg121 in ApxC) is located on the same face of the enzyme as the portion of the active site groove that accommodates a lauryl acyl chain in FeeM (Fig. 7a) suggesting the likely ACP binding site (Fig. 7b, green) and this is the opposite face to which the histone tail locates in the Gcn5 ternary complex (Fig. 7a, blue) suggesting a possible protoxin binding site, (Fig. 7b, blue) . If TAATs do use a ternary complex it seems likely they would also use the direct attack mechanism typical of other GNATs. Otherwise, TAATs will be of significant interest as a truly unique subset of the GNAT superfamily.
Elucidation of the TAAT protein structure, solution oligomer and active site represents a significant step forwards towards understanding how bacterial pore-forming toxins are activated.
The structural and possibly functional distinction between TAATs and all known GNAT families also identifies these enzymes as possible targets for developing new anti-virulence compounds.
METHODS
Cloning and site-directed mutagenesis.
The apxIC gene was PCR-amplified from Actinobacillus pleuropneumoniae (ATCC27088) genomic DNA using primers ApxC QE80 F and ApxC QE80 R (all primer sequences are given in Table S3) engineered to encode restriction sites in the 5'-ends. The PCR product was digested with BamHI and HindIII and ligated into pQE80 (Qiagen). Site-specific mutations were introduced using QuikChange (Stratagene). Clones from PCR-amplified DNA were sequenced (Source Bioscience).
TAAT genes from uropathogenic E.coli, enterohemorrhagic E.coli, Bordetella pertussis, 
Structure analysis, sequence alignments and homology modelling.
Buried surface areas were calculated using AREAIMOL (56) with a solvent probe radius of 1.2Å.
Predicted dimer stability was assessed with PISA (33). Root mean square deviations (rmsds) were calculated over all C α atoms after alignment using superpose in the CCP4 suite (57) . Figures were prepared in Pymol (58) . For homology modelling, a single monomer of ApxC was used as a template on which to impose the sequence of other TAATs using the Phyre2 server in sequence threading mode (59) . For multiple sequence alignments, amino acid sequences were processed using Clustal Omega (60) and conserved residues mapped with ESPript (61) . Further editing to add the secondary structure elements and essential residues was performed manually using the GNU Image Manipulation Programme (GIMP).
Small angle X-ray scattering (SAXS) analysis.
Small angle X-ray scattering was conducted at the PETRA P12 SAXS beamline in Hamburg, Germany (Deutsches Elektronen-Synchrotron -DESY) using purified ApxC protein in buffer 20mM HEPES pH 7.5, 150mM NaCl. Data used in final analysis is the average of 4 separate samples (each the average of 10-20 frames) collected using 56μM ApxC. Computational analysis of the data used the ATSAS package of programs (62) . Inspection and characterisation of the data used PRIMUS (63) and GNOM (64) , while ab initio shape reconstruction used DAMMIN (65). The final particle was constructed by averaging 20 independent models with DAMAVER (66) before filtering with DAMFILT (66) . The final model also used enforced P2 symmetry, but runs without symmetry restraints produced similar results. CRYSOL (67) was used to compare predicted scattering behaviour of dimers/monomers in our crystal structure with scattering data obtained in solution.
Hemolysis assay of toxin activation.
E. coli MC1061 (TolC positive) cells bearing plasmids expressing the export system HlyBD (LG575 (68)) and HlyA (LG583 (68) Bacterial two-hybrid assays.
E.coli BTH101 was co-transformed with recombinant pUT18 and pKNT25 plasmids expressing the protein of interest fused to either the T18 or T25 domain of B.pertussis CyaA and grown at 30°C.
Overnight culture (LB with 100 μg/mL carbenicillin and 50μg/mL kanamycin) grown at 30°C was spotted (2µl) on LB agar containing 0.5mM IPTG and 40µg/mL X-GAL. After overnight incubation at 30°C plates were photographed under white light. β-galactosidase assays were performed as described (69) .
Cross-linking.
Cysteine variants of ApxC were purified as for the wildtype protein except that 2mM TCEP was added to all buffers. For cross-linking reactions, TCEP was removed by desalting column and 100µM CuCl 2 added to 50μg of protein in 25mM HEPES pH7.5, 150mM NaCl and incubated at 25ºC for 30 minutes before addition of 10mM EDTA (to chelate copper) and 5mM NEM (to block free cysteines). Reactions were analysed by SDS PAGE. For the control reaction (pre-block) samples were pretreated with EDTA and NEM prior to addition of CuCl 2 .
Western blot analysis.
Samples were resolved on SDS PAGE, transferred to nitrocellulose membrane and immunoblotted with anti-His (Qiagen) or anti-cyaA (Santa Cruz) antisera as appropriate. These were detected with a chemiluminescence kit (GE Healthcare ECL) or fluorescence imaging (Odyssey Licor) respectively. 
